Columns

Red Mesa Science & Refining: Setting Standards in the Cannabinoid Industry

Jeff Applegate said the company sets itself apart through trust, product consistency, transparency, quality, compliance, and exceptional customer service.

Columns

Opportunities for Berries and Botanicals in Consumer Health Products for 2025

Manufacturers and innovators can stay ahead of the curve to meet consumer demands and usher in the next generation of health-focused products.

Columns

A New Trump Administration Should Revisit the Federal Food, Drug, and Cosmetic Act

Supplements can help manage certain diet-related chronic diseases. They should be allowed to claim that to consumers.

Columns

Southern African Botanical Products Association Explores Access to International Marketplaces

The organization aims to improve quality and supply chains and promote international acceptance of southern African botanical products.

Columns

Informed Use of Medical Cannabis: Expanding Access, Education, and Research

Emily Fisher, founder and CEO of Leafwell, is empowering patients with the knowledge and support they need to integrate cannabis into their treatment plans.

Columns

A Wish List for the Dietary Supplement Industry for 2025

Standardizing definitions, education about the true cost of quality, and advocating for clear labeling can help foster next-level integrity.

Columns

Understanding Preclusion Provisions: When is an ‘Article’ Excluded from Use as a Dietary Ingredient?

FDA hasn’t provided much guidance but here’s a review of the statute and some interpretation.

Columns

The DTC Revolution That’s Reshaped American Healthcare

The patient-practitioner relationship, the technologies that mediate that bond, and the dynamics that influence purchases are all in flux.

Columns

A Fresh Look at Immune Health: It’s Time for a Proactive and Comprehensive Approach

The category has been on a wild ride in recent years. Immune fatigue can’t keep us from recognizing the need for robust and stable immune systems.

Columns

How to Address NDI Issues and Spur Innovation by Updating the FDCA

There are no perfect solutions to the problems that plague the dietary supplement industry, but the existing situation is not tenable.

Columns

Trade, Supplements, Regulations and the 2024 Presidential Candidates

What impact might the candidates have on the dietary supplement industry?

Columns

Are Functional Mushrooms the Next Superfood? Market Demand Continues to Gather Momentum

The market size has been valued at $15.3 billion in 2022 and is expected to surpass the $23.3 billion mark by 2030.

Columns

Chocolate and Cannabis: A Match Made in New Jersey

David Little of Inclusion Gourmet discusses the company’s foray into edibles with products for sleep, pain and energy.

Columns

Rulemaking by Guidance? FDA’s Process for NDIN Procedures and Timeframes

While some aspects are welcome, the agency continues to stray from its task of clarifying the applicable statutory and regulatory requirements.

Columns

Confronting the Myth that Dietary Supplements are ‘Unregulated’ and a ‘Wild West’

In the face of this common refrain, responsible companies in the natural products industry continue to exceed the highest standards.